MLEC

MLEC

NASDAQ

Moolec Science S.A.

11.44

4.49(64.6%)
Volume

10.6M

Market Cap

$8.31M

P/E Ratio

-0.37

EPS

$-258.69


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-0.37

P/B Ratio

-0.62

EPS

$-258.69

ROE

134.49%

Profit Margin

-33.41%

Operating Margin

-3.14%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
DRMA
Dermata Therapeutics, Inc.
$1.32 2.33% -0.21 $899,655 0.00
ELAB
PMGC Holdings Inc.
$3.84 -32.87% 0.00 $67,876 0.34
GLMD
Galmed Pharmaceuticals Ltd.
$0.52 -3.52% -0.33 $2.85M 0.00
GTBP
GT Biopharma, Inc.
$0.45 -1.00% -0.09 $4.73M 0.00
NCEL
NewcelX Ltd.
$2.14 -5.10% -0.40 $963,000 0.00
NKGN
NKGen Biotech, Inc. Common Stock
$0.06 -14.29% -0.12 $7.84M -0.76
TIVC
Tivic Health Systems, Inc.
$0.97 -2.98% -0.03 $1.05M 0.38
VRAX
Virax Biolabs Group Limited
$0.15 -12.18% -0.13 $663,451 0.10
WINT
Windtree Therapeutics, Inc.
$0.01 12.14% 0.00 $389,336 -1.11
XRTX
XORTX Therapeutics Inc.
$2.32 8.03% -0.21 $646,092 0.02

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$157.05

52 Week Low

$3.08

Dividend

$0.00

Dividend Yield

0.00%

About Moolec Science S.A.

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.